The board of directors of RaySearch Laboratories AB (publ) has decided to postpone the Annual General Meeting 2020, previously scheduled to be held on May 19, 2020.

The decision has been made as a precautionary measure considering the rapid spread of the new coronavirus, COVID-19, and the prohibition against holding public gatherings of more than 50 participants.

The Annual General Meeting will be held no later than June 30, 2020 in accordance with applicable legislation and RaySearch will publish an invitation no later than four weeks prior to the new date.

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Peter Thysell, CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare. Over 2,600 clinics in more than 65 countries use RaySearch software to improve lives and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.

About RayCare
RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow's requirements for advanced analytics and decision support in mind.

More information about RaySearch is available at www.raysearchlabs.com

* Subject to regulatory clearance in some markets.

https://news.cision.com/raysearch-laboratories/r/raysearch-postpones-annual-general-meeting-2020,c3086918

https://mb.cision.com/Main/1102/3086918/1228963.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English